Skip to main content
B

BIO-GENE TECHNOLOGY LTD — Investor Relations & Filings

Ticker · BGT ISIN · AU000000BGT8 ASX Professional, scientific and technical activities
Filings indexed 449 across all filing types
Latest filing 2022-11-17 Regulatory Filings
Country AU Australia
Listing ASX BGT

About BIO-GENE TECHNOLOGY LTD

https://bio-gene.com.au/

Bio-Gene Technology Ltd is a technology company focused on the development and commercialization of novel insecticides derived from naturally occurring chemistry. The company addresses the global challenge of insecticide resistance through its proprietary platform based on beta-triketone chemistry. Its primary product candidates include Flavocide, a nature-identical version of a compound found in specific eucalyptus species, and Qcide, a natural oil extract. These solutions are designed for diverse applications, including crop protection, grain storage, public health, and animal health. By utilizing a unique mode of action, the company provides alternatives to traditional chemical pesticides, aiming to deliver effective pest management with a favorable safety profile for non-target organisms and the environment.

Recent filings

Filing Released Lang Actions
Bio-Gene 2022 AGM - CEO's Presentation 4 pages 254.0KB
Regulatory Filings
2022-11-17 English
Results of Meeting 1 page 265.5KB
Regulatory Filings
2022-11-17 English
Appendix 4C - 30 September 2022 8 pages 837.5KB
Regulatory Filings
2022-10-26 English
Significant Developments in Molecule Manufacturing - Update 2 pages 665.2KB
Regulatory Filings
2022-10-25 English
2022 Notice of Annual General Meeting/Proxy Form 19 pages 1.3MB
Regulatory Filings
2022-10-13 English
Notice Required Under ASX Listing Rule 3.13.1 1 pag
Regulatory Filings
2022-09-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.